Skip to main content
CSDX logo

CSDX · Cs Diagnostics Corp. · Shareholders & Ownership

Track CSDX — free
$0.01 At close · Oct 20
Market Cap
$54,936
Shares
137.34M
Volume · Oct 20 28.62K Avg daily vol (15 sessions) 18.07K

Every disclosed holder of CSDX in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.

Who Owns CSDX

No chart: the summed disclosures exceed shares outstanding, so they are not parts of one whole.

Holder group Shares % Out
Institutional (13F) 0 0.00%
Insiders (Forms 3, 4, 5) 196,430,396 143.02%
13D/G-only blocks 26,989,114 19.65%
Remaining 86,079,310 -62.68%
Registered funds (N-PORT, not summed) 0 0.00%

Shares outstanding: 137,340,200, the issuer's latest cover-page count restated onto today's split basis.

Remaining is negative: the summed disclosures exceed shares outstanding, as when filings are dated at different times or holders that do not disclose their links count the same shares. It is flagged, not clipped.

13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.

Holders of CSDX

# Holder Shares
1
CS Diagnostics Pharma GmbH
Insider CIK 2107192 · Dec 31, 2025
10% Owner, issuer-wide
104,507,800
2
CS Interpharm LLC
Insider CIK 2104397 · Dec 31, 2025
10% Owner, issuer-wide
49,362,500
3
CS Interpharm General Trading Co. LLC
Insider CIK 2106403 · Dec 31, 2025
10% Owner, issuer-wide
42,560,096
4
Santoli Antonio
13G CIK 2084392 · Unknown · Sep 30, 2025
Rule 13d-1(c), passive investor
13,596,680
5
Graus Thomas
13G CIK 2082730 · Unknown · Sep 30, 2025
Rule 13d-1(c), passive investor
13,392,434

Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.

Key facts CIK 1106861 CUSIP 33852L202 Visit website Investor relations